Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

537
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
537
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

714
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
714
Survival Tree01:19

Survival Tree

374
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
374
Actuarial Approach01:20

Actuarial Approach

278
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
278

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Secondary cutaneous involvement in peripheral T-cell lymphoma: Diagnostic frameworks, staging integration, and therapeutic implications.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026
Same author

The 2025 measles outbreak in Texas.

BMC infectious diseases·2026
Same author

EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Theory and simulations of delayed stochastic and deterministic models of prion diseases.

Journal of mathematical biology·2026
Same author

Scope of nanobodies in hepatopancreatobiliary oncology.

Drug discovery today·2026
Same author

EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

相关实验视频

Updated: Jan 9, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

472

德克萨斯州乳腺癌患者的生存分析,使用古典和机器学习方法.

Sidketa I Fofana1, Tamer Oraby1, Salique H Shaham2,3

  • 1School of Mathematical and Statistical Sciences, The University of Texas Rio Grande Valley, Edinburg, USA.

Cureus
|December 8, 2025
PubMed
概括

乳腺癌的生存率受到诊断阶段的显著影响,远期癌症的风险要高得多. 早期发现和对弱势群体的支持对于改善患者的治疗结果至关重要.

关键词:
乳腺癌 乳腺癌 乳腺癌克斯比例危险回归卡普兰 - 迈耶曲线在日志级别测试试验中.马哈拉诺比斯与距离相匹配在种族平等的基础上.随机生存森林 随机生存森林

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

相关实验视频

Last Updated: Jan 9, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

472
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

科学领域:

  • 在瘤学瘤学.
  • 流行病学 流行病学
  • 生物统计学 生物统计学

背景情况:

  • 乳腺癌是影响女性的全球领先癌症.
  • 了解生存决定因素对于患者护理和公共卫生战略至关重要.

研究的目的:

  • 确定影响乳腺癌患者长期生存的关键因素.
  • 为了分析德克萨斯州11年的恶性乳腺癌存活率数据.

主要方法:

  • 卡普兰-梅尔曲线和存活率分析的日志等级测试.
  • 考克斯比例危险回归和随机生存森林用于因素识别和预测.
  • 马哈拉诺比斯匹配距离用于估计平均延长寿命.

主要成果:

  • 阶段,横向性,年龄,等级,亚型,激素受体状态,主要部位,种族,收入和治疗方式显著影响生存.
  • 癌症阶段是最关键的预测因素;与局部癌症相比,远期癌症的危险比率为15.869.
  • 局部阶段患者的平均存活时间为67.34个月,而远程阶段患者的平均存活时间为67.34个月.

结论:

  • 诊断时的阶段是乳腺癌生存的最关键因素.
  • 政策建议包括促进早期诊断,查和对老年人和弱势患者的支持.